Susquehanna International Group’s LeMaitre Vascular LMAT Stock Holding History

Susquehanna International Group’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,100	Closed	-$271K	–	13056
2025 Q3	$271K	Buy	+3,100	New	+$277K	﹤0.01%	10342
2024 Q2	–	Sell	-7,800	Closed	-$518K	–	12726
2024 Q1	$518K	Buy	+7,800	New	+$481K	﹤0.01%	8421
2023 Q4	–	Sell	-4,000	Closed	-$218K	–	12885
2023 Q3	$218K	Buy	+4,000	New	+$237K	﹤0.01%	10045
2021 Q3	–	Sell	-4,500	Closed	-$275K	–	13205
2021 Q2	$275K	Sell	4,500 -1,600	-26%	-$85K	﹤0.01%	10967
2021 Q1	$298K	Buy	+6,100	New	+$286K	﹤0.01%	10612
2020 Q4	–	Sell	-7,300	Closed	-$237K	–	11426
2020 Q3	$237K	Buy	+7,300	New	+$219K	﹤0.01%	9174
2020 Q1	–	Sell	-7,900	Closed	-$284K	–	10603
2019 Q4	$284K	Buy	+7,900	New	+$273K	﹤0.01%	8134
2019 Q1	–	Sell	-9,700	Closed	-$229K	–	9409
2018 Q4	$229K	Sell	9,700 -2,600	-21%	-$71K	﹤0.01%	7494
2018 Q3	$477K	Buy	+12,300	New	+$443K	﹤0.01%	6622

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Susquehanna International Group's LMAT Position: Q1 2026 in Review

Susquehanna International Group increased its LeMaitre Vascular (LMAT) stake by 261% in Q1 2026, buying an estimated $668K and bringing the position to 9,694 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #7749.

Susquehanna International Group first reported a position in LMAT in Q4 2016 and has held it in 15 quarters since. The position peaked at $2.17M in Q2 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Susquehanna International Group held 9,694 shares of LeMaitre Vascular worth $1.06M as of Q1 2026.
Susquehanna International Group bought 7,006 LeMaitre Vascular shares in Q1 2026, an estimated $668K.
LeMaitre Vascular made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7749 holding.
Susquehanna International Group first reported a position in LeMaitre Vascular in Q4 2016 and has held it in 15 quarters since.
Susquehanna International Group's LeMaitre Vascular position peaked at $2.17M in Q2 2025.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.